Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector.
Saved in:
| Title: | Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. |
|---|---|
| Authors: | Burke BP; Calimmune, Inc., Los Angeles, California, USA., Levin BR; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Zhang J; Calimmune, Inc., Los Angeles, California, USA., Sahakyan A; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Boyer J; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Carroll MV; Calimmune, Inc., Los Angeles, California, USA., Colón JC; Calimmune, Inc., Los Angeles, California, USA., Keech N; Calimmune, Inc., Los Angeles, California, USA., Rezek V; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Bristol G; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Eggers E; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Cortado R; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Boyd MP; Calimmune, Inc., Los Angeles, California, USA., Impey H; Calimmune, Inc., Los Angeles, California, USA., Shimizu S; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Lowe EL; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Ringpis GE; Calimmune, Inc., Los Angeles, California, USA., Kim SG; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Vatakis DN; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Breton LR; Calimmune, Inc., Los Angeles, California, USA., Bartlett JS; Calimmune, Inc., Los Angeles, California, USA., Chen IS; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Kitchen SG; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA., An DS; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA., Symonds GP; Calimmune, Inc., Los Angeles, California, USA. |
| Source: | Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2015 Apr 14; Vol. 4, pp. e236. Date of Electronic Publication: 2015 Apr 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: Electronic Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25872029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Burke+BP%22">Burke BP</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Levin+BR%22">Levin BR</searchLink>; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Sahakyan+A%22">Sahakyan A</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Boyer+J%22">Boyer J</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Carroll+MV%22">Carroll MV</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Colón+JC%22">Colón JC</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Keech+N%22">Keech N</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Rezek+V%22">Rezek V</searchLink>; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Bristol+G%22">Bristol G</searchLink>; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Eggers+E%22">Eggers E</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Cortado+R%22">Cortado R</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Boyd+MP%22">Boyd MP</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Impey+H%22">Impey H</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Shimizu+S%22">Shimizu S</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Lowe+EL%22">Lowe EL</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Ringpis+GE%22">Ringpis GE</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Kim+SG%22">Kim SG</searchLink>; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Vatakis+DN%22">Vatakis DN</searchLink>; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Breton+LR%22">Breton LR</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Bartlett+JS%22">Bartlett JS</searchLink>; Calimmune, Inc., Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Chen+IS%22">Chen IS</searchLink>; Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Kitchen+SG%22">Kitchen SG</searchLink>; Division of Hematology-Oncology and the UCLA Center for AIDS Research (CFAR), David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22An+DS%22">An DS</searchLink>; School of Nursing at UCLA, UCLA AIDS Institute, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Symonds+GP%22">Symonds GP</searchLink>; Calimmune, Inc., Los Angeles, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2015 Apr 14; Vol. 4, pp. e236. <i>Date of Electronic Publication: </i>2015 Apr 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25872029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/mtna.2015.10 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e236 Titles: – TitleFull: Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Burke BP – PersonEntity: Name: NameFull: Levin BR – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Sahakyan A – PersonEntity: Name: NameFull: Boyer J – PersonEntity: Name: NameFull: Carroll MV – PersonEntity: Name: NameFull: Colón JC – PersonEntity: Name: NameFull: Keech N – PersonEntity: Name: NameFull: Rezek V – PersonEntity: Name: NameFull: Bristol G – PersonEntity: Name: NameFull: Eggers E – PersonEntity: Name: NameFull: Cortado R – PersonEntity: Name: NameFull: Boyd MP – PersonEntity: Name: NameFull: Impey H – PersonEntity: Name: NameFull: Shimizu S – PersonEntity: Name: NameFull: Lowe EL – PersonEntity: Name: NameFull: Ringpis GE – PersonEntity: Name: NameFull: Kim SG – PersonEntity: Name: NameFull: Vatakis DN – PersonEntity: Name: NameFull: Breton LR – PersonEntity: Name: NameFull: Bartlett JS – PersonEntity: Name: NameFull: Chen IS – PersonEntity: Name: NameFull: Kitchen SG – PersonEntity: Name: NameFull: An DS – PersonEntity: Name: NameFull: Symonds GP IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 04 Text: 2015 Apr 14 Type: published Y: 2015 Identifiers: – Type: issn-print Value: 2162-2531 Numbering: – Type: volume Value: 4 Titles: – TitleFull: Molecular therapy. Nucleic acids Type: main |
| ResultId | 1 |